Statins Carry Small Risk Of Diabetes, FDA Warns

Law360, New York (February 28, 2012, 7:12 PM EST) -- Patients who take cholesterol-lowering drugs known as statins, some of the most popular drugs in the country, may be at a slightly higher risk of high blood sugar levels and Type 2 diabetes, the U.S. Food and Drug Administration said Tuesday.

Statins, a class of drug that includes Pfizer Inc.'s Lipitor, will be required to carry a warning of what the FDA said was “a small increased risk” of hyperglycemia and diagnosis of Type 2 diabetes.

The FDA said it was also changing the labeling requirements...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.